M
any studies have shown that the stiffness of elastic arteries like the aorta independently predicts cardiovascular risk [1] [2] [3] . The predictive value of aortic stiffness, measured as carotid-femoral pulse wave velocity (PWV), was largely superior in the Framingham Heart Study to brachial artery stiffness (carotid-radial PWV), augmentation index, central pulse pressure and pulse pressure amplification [4] . The same holds in patients with end-stage renal disease, with carotid-femoral PWV (cfPWV) also superior to brachial artery and femorotibial stiffness [5] . By directly reflecting arterial stiffness, having the best predictive value for cardiovascular events and the ease of its measurement, cfPWV is now considered the gold standard for arterial stiffness assessment [1] . The 2007 European Society of Hypertension-European Society of Cardiology (ESH-ESC) Guidelines for the Management of Hypertension consider a high cfPWV as target organ damage [6] .
Carotid-femoral PWV is calculated by dividing traveled distance by transit time (PWV ¼ distance/time). The large majority of devices quite accurately measure transit time as the time delay between the arrival of the pulse wave at the common carotid artery and the common femoral artery. This measurement can be done directly on the same pulse wave, or indirectly by subtracting the time delay between the R top of the electrocardiogram to the common carotid artery from the time delay between the R top of the electrocardiogram to the common femoral artery. The traveled distance should also be measured accurately since small differences may influence the absolute value of PWV [1, 7] . However, there is no consensus on how this distance is ideally measured and many different distances have been proposed (Table 1) . A standardization of the measurement technique is requested since each distance definition results in a different PWV value [8, 9] increasing confusion among users. Whereas the cut-off value of 12 m/s in the European guidelines [6] only applies to the full (100%) direct carotidfemoral (common carotid artery-common femoral artery) distance, the recently published reference values are based on 80% of the common carotid artery-common femoral artery distance [7] . In addition, although conversion formulas have been proposed to calculate subtracted distance (suprasternal notch to common femoral artery minus suprasternal notch to common carotid artery) from direct distance and vice versa [10] , these formulas are approximations and introduce additional error.
Recently different proposed distances have been compared with the real traveled distance measured by magnetic resonance imaging (MRI). From the MRI images a centerline was constructed in the lumen of the arteries. Following these arterial centerlines, the real traveled distance was defined as the ascending aorta (from aortic valve) to right common femoral artery distance minus ascending aorta to right common carotid artery distance [11] . This study showed that the direct carotid-femoral distance largely overestimates the real traveled distance by 25.4%, whereas the subtracted distances using the distances to common femoral artery and common carotid artery from suprasternal and sternal notch substantially underestimate the real traveled distance by 10.3 and 29.2%, respectively. Of all currently used distances the 80% of the direct carotid-femoral distance (common carotid artery À common femoral artery Â 0.8) appeared the most accurate, only slightly overestimating the real traveled distance by 0.4%. Two other estimates performing relatively well were both based on body height (body height/4 þ 7.28 proposed by Weber et al. [12] and body height Â 0.29 proposed by Filipovsky et al. [13] ) underestimating the traveled distance by 1.0 and 1.8%, respectively. The model obtained from a multiple linear regression analysis (r 2 ¼ 0.64) was: real traveled distance ¼ (0.286 Â common carotid artery À common femoral artery) þ (0.101 Â age) þ (0.159 Â weight) þ 16.165, with common carotid artery À common femoral artery in cm, age in years and weight in kg.
This best fit formula appears too complicated to be applied in daily practice, unless built in a dedicated device.
The same study also confirmed the data by Sugawara et al. [14] , showing a distance which increases with age. In the population studied by Huybrechts et al. [11] , the variation in distance between the (common carotid artery À common femoral artery Â 0.8) tape measure distance and the MRI measured real traveled distance was largely explained by increasing age (30%) and to a much smaller extent by body mass index (BMI; 4%). Therefore, it was tested in the same population whether a simple and for daily practice acceptable modification of the (common carotid artery À common femoral artery Â 0.8) distance taking into account age would be more accurate. The tested formula adjusts the (common carotid artery À common femoral artery Â 0.8) distance for age by adding 1 mm/year for an age above 50 and subtracting 1 mm/year for an age below 50, respectively (Table 2 ). Although on the population level (Table 2a) this age-adjusted formula performed better; this was not the case on an individual level in the age group between 50 and 76 years (Table 2b) , which may be considered the more relevant group for targeting. More data in the very elderly may be needed. Thus, at this stage, we advise to use the simple unadjusted (common carotid artery À common femoral artery Â 0.8) distance as standard distance for daily practice, for three main reasons: the age adjustment did not perform better in the older age group; the adjusted formula is less easy to use in daily practice; and as in the study by Sugawara et al. [14] the age-dependent elongation of the aortic path length is limited.
This consensus panel is aware that the so-called 'real' traveled distance of cfPWV is not a simple unidirectional path length since at the time the pulse wave travels up the brachiocephalic and carotid artery, it also travels down the aortic arch. MRI measurements as outlined above are valid only after the assumption that these velocities are the same in both directions, and this may not be the case. In animals PWV in the carotid artery may be higher by 2-3 m/s than in the aortic arch [15] . Rough calculations from studies showing both common carotid stiffness and cfPWV suggest that the difference in PWV between common carotid artery and aortic arch/descending aorta may be smaller in humans [16] and is probably affecting cfPWV less than 3%. The present data also are based on measurements at the right common carotid artery and common femoral artery. It is not excluded that this may be slightly different for measurements at the left side.
The current cut-off value, proposed in the 2007 ESH-ESC Guidelines for the Management of Hypertension [6] , is 12 m/s, above which there is an increased risk for cardiovascular events. This value was selected because it corresponded to a rough estimate of high cardiovascular risk from longitudinal data available at that time in different populations of hypertensive patients [17, 18] , older adults [19] and in the general population [20] . Since that time, many other studies provided either longitudinal [2, 4, 21] or cross-sectional [7] data supporting this cut-off value. This cut-off value of 12 m/s was based on the 100% direct common carotid artery À common femoral artery distance measurement. Adapted to the new standard distance (common carotid artery À common femoral artery Â 0.8), it would become 9.6 m/s. We propose 10 m/s as new standard cut-off value for cfPWV, because this is an easy figure to use in daily practice. In addition, and more important, this value is at the upper part of the second quartile in the Framingham Heart Study and represents in this general population with a mean age of 63 years about 4% risk for a first major cardiovascular event within the next 8 years [4] . One should be aware of the limitations of the use of a fixed cut-off value. The 2007 guidelines mention that 'although the relationship between aortic stiffness and events is continuous, the threshold has been suggested as a conservative estimate of significant alterations of aortic function in middle-aged hypertensive patients'. It, therefore, is not obvious that a fixed age and BP-independent cut-off value is the best risk predictor in different populations [7] . This should be further investigated. Finally, one should keep in mind that as for BP measurement, standardization of patient conditions and repeated measurements is of utmost importance [1, 22, 23] . We advise to perform at least two measurements. If these differ by more than 0.5 m/s, a third measurement should be performed. The PWV value should be the median of those measurements. The median value has the advantage over the mean value that the operator does not have to calculate and that the influence of outliers is reduced or ruled out. In addition, it is also very important to take the tape measure distance in a straight line. If this is not possible as in severe obesity, an infantometer used upsidedown can provide a more reliable distance measurement. These other recommendations on user procedures are summarized below.
Other recommendations on user procedures (adapted from [1, 22, 23] ):
(1) Measurements should be performed in a quiet room with stable room temperature. In conclusion, this expert consensus document advises to standardize patient conditions and user procedures for the measurement of aortic stiffness using cfPWV (see Box 1) . It advises to use 80% of the direct carotid-femoral (common carotid artery À common femoral artery Â 0.8) tape measure distance as new standard for daily practice, because this appears to be the most accurate body surface distance estimate, is easy to use, and is less influenced by large bellies and large breasts. In addition, it allows the use 
